20 completed, 8 recruiting, 3 unknown, 1 active not recruiting. 34 Phase 2, 7 Phase 3, 4 Phase 1.
Follow Mesalamine: new trials by email Literature Review of Mesalamine trials Research Report on Mesalamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Desloratadine in Patients With Ulcerative Colitis Desloratadine, mesalamine - Ulcerative Colitis (UC), Ulcerative Colitis | Phase 2 | Recruiting | Tanta University | 44 | 2026-01-26 | 2026-01-29 |
| Pentoxifylline in Patients With Ulcerative Colitis Mesalamine, Pentoxifylline - Inflammatory Bowel Diseases | Phase 2 | Recruiting | Ihab Elsayed Hassan | 60 | 2026-01-20 | 2026-04-15 |
| Rupatadine in Patients With Ulcerative Colitis Mesalamine, Rupatadine - Ulcerative Colitis | Phase 2 | Recruiting | Alexandria University | 60 | 2025-07-15 | 2025-11-19 |
| Nitazoxanide in Patients With Ulcerative Colitis Mesalamine, Nitazoxanide - Ulcerative Colitis | Phase 2 | Recruiting | Alexandria University | 70 | 2025-05-30 | 2025-06-27 |
| Beneficial Effect of Silymarin in Ulcerative Colitis Silymarin, Mesalamine, Azathioprine - Ulcerative Colitis | Phase 2 | Recruiting | Tanta University | 44 | 2025-02-01 | 2025-03-05 |
| Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo) Mesalamine - Immune-related Adverse Event, Diarrhea | Phase 2 | Recruiting | AHS Cancer Control Alberta | 20 | 2024-08-20 | 2026-11-04 |
| Minocyclin in Ulcerative Colitis as Added on Therapy Mesalazine, Minocycline - Inflammatory Bowel Diseases | Phase 2 | Completed | Mostafa Bahaa | 46 | 2024-01-22 | 2025-11-18 |
| Dapagliflozin in Patients With Ulcerative Colitis Mesalamine, Dapagliflozin 10mg Tab - Inflammatory Bowel Diseases | Phase 2 / Phase 3 | Completed | Mostafa Bahaa | 60 | 2023-08-20 | 2026-09-21 |
| Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis Mesalamine, Nifuroxazide - Inflammatory Bowel Diseases | Phase 2 / Phase 3 | Completed | Mostafa Bahaa | 50 | 2023-08-20 | 2026-10-13 |
| Repurposing Fenofibrate in Modulating AMPK/NLRP3 Inflammasome in Patients With Ulcerative Colitis Mesalamine, Fenofibrate - Inflammatory Bowel Diseases | Phase 2 | Completed | Tanta University | 70 | 2023-03-20 | 2026-10-13 |
| Fenofibrate in Ulcerative Colitis Mesalamine, Fenofibrate 160mg - Inflammatory Bowel Diseases | Phase 2 / Phase 3 | Completed | Tanta University | 60 | 2023-02-28 | 2026-05-04 |
| Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis Atorvastatin 80mg, Mesalamine - Inflammatory Bowel Diseases | Phase 2 | Completed | Tanta University | 54 | 2023-02-01 | 2025-11-18 |
| Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis Hydroxychloroquine, Mesalamine - Ulcerative Colitis (Disorder) | Phase 1 / Phase 2 | Active not recruiting | Icahn School of Medicine at Mount Sinai | 3 | 2022-06-10 | 2025-02-11 |
| Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome Mesalamine, Placebo - Lynch Syndrome, Colon Cancer | Phase 2 | Recruiting | Ann-Sofie Backman | 150 | 2022-03-21 | 2024-12-17 |
| Fecal Microbiota Transplantation for Ulcerative Colitis Fecal microbiota transplantation, Infusion of Saline, 5-Aminosalicylic acid(5-ASA) and/or Prednisone - Ulcerative Colitis, Fecal Microbiota Transplantation | Phase 2 / Phase 3 | Recruiting | Guangzhou First People's Hospital | 120 | 2019-01-20 | 2019-01-15 |
| Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome mesalamine 2400 MG (5-ASA), mesalamine 1200 MG, Placebo - Colorectal Cancer | Phase 2 | Terminated | Christoph Gasche | 8 | 2017-11-24 | 2019-04-18 |
| Faecal Bacteriotherapy for Ulcerative Colitis Faecal bacterial transplantation, Mesalazine 4G Enema - Ulcerative Colitis | Phase 2 | Completed | Institute for Clinical and Experimental Medicine | 61 | 2017-06-19 | 2021-10-01 |
| Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease FMT, Mesalazine - Inflammatory Bowel Disease, Ulcerative Colitis | Phase 2 | Unknown | Yanling Wei | 40 | 2015-01-01 | 2015-01-09 |
| Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis parasitological diagnostics (coproscopy), Nitazoxanide 500Mg Oral Tablet, Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet - Ulcerative Colitis, Ulcerative Colitis Exacerbation | Phase 1 / Phase 2 | Unknown | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | 300 | 2015-01-01 | 2023-03-03 |
| Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission Mesalazine, Tripterygium glycosides - Inflammatory Bowel Diseases, Crohn's Disease | Phase 2 / Phase 3 | Unknown | Zhu Weiming | 40 | 2014-01-01 | 2014-01-24 |
Showing 20 of 34. Sign in to see all of them.
Colitis, Ulcerative (11) · Inflammatory Bowel Diseases (10) · Irritable Bowel Syndrome (3) · Colorectal Neoplasms (2) · Colorectal Neoplasms, Hereditary Nonpolyposis (2) · Crohn Disease (2) · Diarrhea (2) · Abdominal Pain (1) · Adenoma (1) · Berylliosis (1) · Colitis (1) · Colitis, Microscopic (1) · Colonic Neoplasms (1) · Diabetes Mellitus, Insulin-Dependent, 12 (1) · Digestive System Diseases (1)
Tanta University (5) · Mostafa Bahaa (3) · Alexandria University (2) · Dr. Falk Pharma GmbH (2) · SOFAR S.p.A. (2) · AHS Cancer Control Alberta (1) · Ann-Sofie Backman (1) · Christoph Gasche (1) · Guangzhou First People's Hospital (1) · Hans Törnblom (1) · Icahn School of Medicine at Mount Sinai (1) · Ihab Elsayed Hassan (1) · Institute for Clinical and Experimental Medicine (1) · Kelsey Jones (1) · Mayo Clinic (1)
Egypt (11) · United States (6) · China (3) · Germany (3) · Sweden (3) · Belgium (2) · Italy (2) · Netherlands (2) · Austria (1) · Canada (1) · Czechia (1) · Denmark (1) · Hungary (1) · Israel (1) · Kenya (1)
Ana Balske, MD, PhD (1) · Ann-Sofie Backman, MD PhD (1) · Baharak Moshiree, MD, MS (1) · Brian Day, PhD (1) · Britta Siegmund, Professor (1) · Dalia R Mohammed ElAfify, Asst.Prof (1) · Dongfeng Chen, doctor (1) · Federico Buffoli, Doctor (1) · Giovanni Barbara, MD (1) · Hussein A ElAmin Hammam, Professor (1) · Judy H Cho, MD (1) · Kelsey DJ Jones, MBBS BA MRCPCH (1) · Lisa A. Maier, M.D., MSPH (1)
PMID 16984503, PMID 22605655, PMID 23414061, PMID 23426454, PMID 25189855, PMID 25192498, PMID 29702300, PMID 33188747, PMID 39575188, PMID 40620467, PMID 41128897, PMID 41213710, PMID 41235106, PMID 41330887